Prevision Medicine
Latest round
- Seed
Last raised
- Sep 2026
Total raised
- $5.4M
Investors
- 3
About Prevision Medicine
Founded in 2024 and based in Schlieren, Switzerland, Prevision Medicine AG provides ex vivo drug testing services through its PrevisionOne platform, which analyzes patients’ living cancer cells against drugs and drug combinations and delivers clinical reports to help oncologists select treatment options.
Who invested in Prevision Medicine
3 investors across 1 round
See all investors in Prevision Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 14, 2026
Amount
$5.4M
Investors
Questions about Prevision Medicine
Who invested in Prevision Medicine?
Prevision Medicine has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prevision Medicine raised?
Prevision Medicine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Prevision Medicine last raise money?
Prevision Medicine's most recent round on record is a Seed, in Sep 2026.
What does Prevision Medicine do?
Founded in 2024 and based in Schlieren, Switzerland, Prevision Medicine AG provides ex vivo drug testing services through its PrevisionOne platform, which analyzes patients’ living cancer cells against drugs and drug combinations and delivers clinical reports to help oncologists select treatment options.
Where is Prevision Medicine headquartered?
Prevision Medicine is headquartered in Schlieren, Switzerland.
Which VCs invest in companies like Prevision Medicine?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back healthcare specialists companies at Prevision Medicine's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Seed
Raising like Prevision Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.